Transport to a PCI centre improved long-term outcome more than thrombolytic therapy at the community hospital in acute MI

摘要

Patients presenting to acute care facilities with STEMI are candidatesnfor therapies of proven, but time-sensitive, effectiveness (1). PCI hasnlargely replaced fibrinolytic therapy in settings in which both are available.nPhysicians in hospitals where PCI is unavailable must choosenbetween offering immediate fibrinolytic therapy or transport to a PCInfacility. A review by Dalby and colleagues found that patients randomizednto transport had reduced short-term incidence of death, reinfarction,nor stroke (2). The latest report on follow-up data from thenPRAGUE-2 trial by Widimsky and colleagues shows that these observationsnwill probably translate into long-term benefits.